Skip to main content
. 2017 Jun 13;8:684. doi: 10.3389/fimmu.2017.00684

Figure 1.

Figure 1

In vitro release profile of the chimeric peptides from peptide-based poly(lactic-co-glycolic) acid (PLGA) nanoformulations. Time-dependent release of chCPAp and monophosphoryl lipid A (MPLA) adjuvant from PLGA-chCPAp-MPLA nanoformulations (A), chH1p and MPLA adjuvant from PLGA-chH1p-MPLA nanoformulations (B), and chKMP-11p and MPLA adjuvant from PLGA-chKMP-11p-MPLA nanoformulations (C) into PBS at 37°C. Data represent the mean ± SD of three independent experiments.